Fact.MR – A Market Research and Competitive Intelligence Provider: As per latest Fact.MR analysis, the global fetal and neonatal heart monitor market is projected to grow at a steady CAGR of 5.5% between 2018 and 2028.
Cardiotocograph (CTG) to Remain the Most Used Means of Monitoring Fetal and Prenatal Heart Rate
Fact.MR’s latest report on fetal and neonatal heart monitor market offers compelling insights on key factors expected to fuel demand through 2028. The report further attempts to uncover various emerging opportunities across leading segments in terms of product type, modality, end user and region. It also highlights strategies adopted by prominent players to dominate the market.
Fact.MR – A Market Research and Competitive Intelligence Provider: As per latest Fact.MR analysis, the global fetal and neonatal heart monitor market is projected to grow at a steady CAGR of 5.5% between 2018 and 2028.
Increasing prevalence of premature birth and rising need for monitoring the fetal and neonatal heart rate are some of the factors driving the market.
Fetal and neonatal heart monitors are devices that are routinely used in gynecology and obstetrics interventions to examine and monitor fetal and neonatal heart rate. Continuous recording of fetal heart rate (FHR) gives reliable information on the condition of the fetus and hence helps the expert to take proper steps for treating the underlying problem.
Rising number of premature birth cases is the primary factor fueling the sales of fetal and neonatal monitors. According to the World Health Organization (WHO), an estimated 15 million babies are born preterm each year. Moreover, around 1 Mn people die each year due to complications of preterm birth.
Consecutively, government and other healthcare organizations are putting various efforts to address the rising cases of stillbirths. Huge investments are being made to modernize the healthcare setups. This is anticipated to boost the sales of fetal heart monitoring devices over the forecast period.
For More Valuable Information on Market Dynamics, Request a Report Sample
https://www.factmr.com/connectus/sample?flag=S&rep_id=750
Further, Fact.MR opines, leading market players are integrating modern technologies for developing advanced and cost-effective products. New fetal heart rate (FHR) monitoring products are being introduced in the market for advanced fetal heart monitoring.
As per the study, cardiotocograph will continue to remain the most preferred product type due to its ability to monitor the fetal heart rate (FHR) as well as the contractions in the womb (uterus).
Moreover, electronic fetal monitoring (EFM) using cardiotocography is gaining widespread popularity for assessment of fetal well-being during labor and delivery. It is being extensively used for interpretation of fetal and neonatal heart rate in order to prevent hypoxia.
Regionally, North America is likely to remain the most lucrative market for fetal and neonatal heart monitors. Growth in the region is attributed to the strong presence of leading medical device manufacturers, highly developed healthcare infrastructure, favorable reimbursement policies and increasing cases of premature births.
It is estimated that premature births account for nearly 10% of the newborn babies annually across the U.S.
“Rising need for monitoring fetal heart rate (FHR) for proper assessment of fetal wellbeing will continue to accelerate the growth of fetal and prenatal heart monitor market over the forecast period. Moreover, increasing efforts of government to reduce the number of stillbirth cases will bode well for the market,” says a Fact.MR analyst
Key Takeaways from Fetal and Neonatal Heart Monitor Market Survey
- The U.S. will continue to dominate the fetal and neonatal monitor market on account of high premature birth rate, increasing spending on fetal and neonatal care and presence of leading medical device manufacturers.
- With continuous product approvals and expanding healthcare infrastructure, Europe is likely to emerge as a lucrative market for fetal and neonatal monitors during the forecast period.
- India and China, collectively, are poised to register strong growth as a result of increasing health awareness, rising government support and soaring cases of premature birth due to late marriages.
- By product type, cardiotocograph segment is likely to dominate the fetal and neonatal heart monitor market.
- Hospitals segment is likely to remain the most lucrative end user for fetal and neonatal heart monitor over the assessment period.
Key Drivers
- Expansion of healthcare infrastructure and increasing penetration of fetal heart monitoring devices across emerging economies will create lucrative growth prospects in the fetal and neonatal heart monitor market.
- Growing adoption of fetal and neonatal heart monitoring devices for reducing the stillbirth cases is positively impacting the market growth.
- New product launches with advanced monitoring features will continue to boost the sales of fetal and neonatal heart monitor over the forecast period.
Key Restraints
- Low penetration of fetal and neonatal heart monitoring devices across underdeveloped regions is restraining the growth of the market.
To learn more about Fetal and Neonatal Heart Monitor Market, you can get in touch with our Analyst at
https://www.factmr.com/connectus/sample?flag=AE&rep_id=750
Competitive Landscape
Leading players operating in the fetal and neonatal heart monitor market are continuously innovating their products. They have adopted various growth strategies such as mergers, partnerships, advanced product launches & approvals, contracts and acquisitions to dominate the market.
- In September 2021, Natus Medical Incorporated, announced the award of a 5-year contract to include Natus Patient Monitoring and Capital Equipment (PMCE) in the electronic catalog (ECAT). The PMCE contract and ECAT integration will now provide easier access for the Department of Defense (DoD) and Veterans Affairs (VA) health systems to purchase many products across the Natus portfolio, including neurodiagnostic, audiology and newborn care equipment and supplies.
- In June 2020, Royal Philips, a global leader in health technology, launched new obstetrics monitoring solution “Avalon CL Fetal and Maternal Pod and Patch” to support clinicians and expectant mothers during COVID-19 pandemic.
- In March 2017, GE Healthcare expanded its Maternal-Infant Care business with the acquisition of Monica Healthcare, a monitoring technology company based in the United Kingdom. This acquisition enhances GE Healthcare’s mobile and digital offerings by providing clinicians and patients around the world with more innovative solutions for labor, delivery, and home care.
Some of the prominent players operating in the fetal and neonatal heart monitor market profiled by Fact.MR are:
- GE Healthcare
- Dragerwerk
- Medtronic
- Smiths Medical
- Getinge Group
- Koninklijke Philips
- Natus Medical
- Others
More Insights on the Global Fetal and Neonatal Heart Monitor Sales Outlook
Fact.MR provides an unbiased analysis of fetal and neonatal heart monitor market, presenting historical demand data (2013-2017) and forecast statistics for the period from 2018-2028. The study divulges compelling insights on the global demand for fetal and neonatal heart monitor with a detailed segmentation on the basis of:
Product Type
- Cardiotocograph
- Doppler
- Accessories
Modality
- Table Top Devices
- Portable and Hand Held Devices
End-User
- Hospitals
- Neonatal Clinics
- Ambulatory Surgical Centers
- Diagnostic Centers
Region
- North America
- Latin America
- Europe
- Japan
- APEJ
- MEA
Key Questions Covered in the Fetal and Neonatal Heart Monitor Market Outlook Report
- The report offers insight into fetal and neonatal heart monitor demand outlook for 2018-2028
- The market study also highlights projected sales growth for fetal and neonatal heart monitor market between 2018 and 2028
- Fetal and neonatal heart monitor market survey identifies key growth drivers, restraints, and other forces impacting prevailing trends and evaluation of current market size and forecast and technological advancements within the industry
- Fetal and neonatal heart monitor market share analysis of the key companies within the industry and coverage of strategies such as mergers & acquisitions, joint ventures, collaborations or partnerships, and others
Explore Fact.MR’s Coverage on the Healthcare Domain –
Heart Failure Monitoring Systems Market Insights - Heart failure monitoring systems market will be primarily driven by rising demand for healthcare services due to an increase in the number of patients as a result of ageing populations, an increase in unhealthy lifestyles, and the introduction of new advanced products for heart failure monitoring. The rise in obesity among younger people is the leading cause of heart failure, and reimbursement policies and government initiatives are driving the market for heart failure monitoring devices.
Neonatal Monitoring Equipment Market Scope - Neonatal monitoring equipment manufacturers' increased interest in providing technologically integrated and high-end solutions reflects the healthcare industry's shift toward value-based care. New neonatal monitoring equipment manufacturers' innovative technology solutions, combined with their appealing price, have prompted large corporations to broaden their product line to satisfy the needs of neonatal intensive care units (NICUs). Medtronic Plc, Natus Medical, Inc., Koninklijke Philips NV, and others are modernising their portfolios to make them more cost-effective, preserve the hospital-to-home point-of-care (PoC) continuum, and incorporate value-added services.
Ambulatory Heart Monitor Market Forecast - Due to an increase in CVD cases caused by numerous cardiac difficulties created by stressful environments and hereditary abnormalities such as catecholaminergic polymorphic ventricular tachycardia and QT syndrome, ambulatory heart monitors have experienced a surge in demand. Mobile cardiac telemetry, Holter monitors, and event monitors are all examples of ambulatory heart monitors. With increased cardiovascular diseases, an ageing population, high demand for ambulatory heart monitors for their usefulness, efficacy, and cost-effectiveness, and technological advancements, the global ambulatory heart monitor market is expected to grow.
About Fact.MR
Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range – from automotive & industry 4.0 to healthcare, technology to even the most niche categories. 80% of Fortune 1000's trust us in critical decision making.
MarketNgage is powered by Fact.MR – our Unified Intelligence Engine, a revolutionary Market Research Subscription platform with a flexible pricing to suit your needs.
You can access all our healthcare research reports by signing up with MarketNgage’s Market Research Subscription with FREE credits. MarketNgage is powered by Fact.MR – A Fully integrated research solution for seamless single-window access Widest coverage on emerging markets, nascent products, and disruptive technologies.
Contact:
Mahendra Singh
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Source: Fact.MR